111In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide (NuView/University of New Mexico)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name111In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide (NuView/University of New Mexico)
Drug Alias Nameimaging agent (NuView)111In-DOTA-GlyGlu-CycMSH (NuView/University of New Mexico)
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNuview Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A